Framework Agreement for Consumables, Reagents and Kits for the Bio-Plex 200 System

Norsk Helsenett SF

The Norwegian Institute of Public Health (NIPH) would like to enter into a framework agreement with a tenderer for the procurement of consumables, reagents and kits for use in the Bio-Plex 200 system. NIPH has 4 Bio-Plex 200 system instruments from Bio-Rad. These instruments are based on Luminex's platform for multiplex-analyses.
NIPH mainly uses the multiplex/Luminex technology in its various research projects. It is therefore important that the tenderer has a broad spectrum of different types of kits (mainly for human samples) and that they are compatible with the contracting authority's pre-activated (COOH) balls that they can connect separate antigens to in order to establish in-house analyses.

Frist

Fristen for mottak av tilbud var 2020-09-01. Anskaffelsen ble publisert 2020-06-30.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2020-06-30 Kunngjøring av konkurranse
Kunngjøring av konkurranse (2020-06-30)
Gjenstand
Anskaffelsens omfang
Tittel: Laboratory reagents
Referansenummer: 20/00818
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) would like to enter into a framework agreement with a tenderer for the procurement of consumables, reagents and kits for use in the Bio-Plex 200 system. NIPH has 4 Bio-Plex 200 system instruments from Bio-Rad. These instruments are based on Luminex's platform for multiplex-analyses. NIPH mainly uses the multiplex/Luminex technology in its various research projects. It is therefore important that the tenderer has a broad spectrum of different types of kits (mainly for human samples) and that they are compatible with the contracting authority's pre-activated (COOH) balls that they can connect separate antigens to in order to establish in-house analyses.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS)
Felles innkjøpsordliste (CPV)
Kode: Laboratoriereagenser 📦
Tilleggs-CPV: Medisinske forbruksvarer 📦
Utførelsessted
NUTS-region: Oslo 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Nasjonalt eller føderalt byrå/kontor
Navn på tildelende myndighet: Norsk Helsenett SF
Postadresse: Abels gate 9
Postnummer: 7030
Poststed: Trondheim
Kontakt
Internettadresse: https://permalink.mercell.com/131596685.aspx 🌏
E-post: brian.mariampillai@nhn.no 📧
URL for dokumenter: https://permalink.mercell.com/131596685.aspx 🌏
URL for deltakelse: https://permalink.mercell.com/131596685.aspx 🌏

Referanse
Datoer
Sendt dato: 2020-06-30 📅
Innleveringsfrist: 2020-09-01 📅
Publiseringsdato: 2020-07-02 📅
Startdato: 2020-10-01 📅
Sluttdato: 2024-10-01 📅
Identifikatorer
Kunngjøringsnummer: 2020/S 126-309217
OJ-S-utgave: 126

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) would like to enter into a framework agreement with a tenderer for the procurement of consumables, reagents and kits for use in the Bio-Plex 200 system. NIPH has 4 Bio-Plex 200 system instruments from Bio-Rad. These instruments are based on Luminex's platform for multiplex-analyses.
Vis mer
NIPH mainly uses the multiplex/Luminex technology in its various research projects. It is therefore important that the tenderer has a broad spectrum of different types of kits (mainly for human samples) and that they are compatible with the contracting authority's pre-activated (COOH) balls that they can connect separate antigens to in order to establish in-house analyses.
Vis mer
Estimert totalverdi: 1 400 000 NOK 💰
Kort beskrivelse:
NIPH manages a large project on monitoring the human papilloma virus. The aim of the project is to study the effect of the vaccine and what genotypes occur in a specific population after vaccination over time. Urine samples are collected annually from girls and boys who are vaccinated against HPV. The urine samples are screened for the presence of 37 different genotypes of HPV based on the luminex method. A generic PCR is carried out in this method that amplifies all 37 genotypes of HPV. Then magnetic balls are used that are connected to specific probes that hybridise to a matching genotype. Positive hybridisation is read by a fluorescent signal when it goes through the luminex machine. The results are a guideline in the follow-up of the effect of the vaccine. 20 000 samples are tested annually with a view to the presence of HPV.
Vis mer
In addition, there are several other research projects that use the luminex method in order to examine immunity after vaccination by detecting antibodies in serum against vaccines from, amongst other things, the child vaccination programme, based on the multiplex method (MMR, DTP). Between 2 000-4 000 samples are tested annually for antibody detection in serum with the luminex method in research projects.
Vis mer
NIPH currently has four Bio-Plex 200 instruments from Bio-Rad. The existing use of reagents and consumables in the Bio-Plex 200 system as described above activates a need for a framework agreement for the procurement of reagents that can increase the efficiency of the order flow, while at the same time the tests are to produce/present specified results.
Vis mer
Estimert verdi eksklusive mva: 1 400 000 NOK 💰
Beskrivelse av fornyelser:
The contract will be valid for 2 years from the date the contract is signed, with an option for a contract extension for 1 + 1 year. The maximum contract period will be until 1 October 2024.
Beskrivelse av opsjoner:
The contract will be valid for 2 years from the date the contract is signed, with an option for a contract extension for 1 + 1 year. The maximum contract period will be until 1 October 2024.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
Tenderers must be registered in a trade register in the member state where the tenderer is established. As described in annex XI of directive 2014/24/EU; suppliers from certain member countries can be required to fulfil other requirements in the mentioned annex.
Vis mer
Minste nivå(er) av standarder:
Requirement: tenderers must have sufficient economic and financial capacity to fulfil the contract.
Documentation requirement: the requirement must be documented with a credit rating based on the last known fiscal figures. The rating must be carried out by a credit rating company with licence to conduct such a service. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Vis mer
Requirement: tenderers must have experience from equivalent contracts. Documentation requirement: description of the most important and comparable deliveries in the last 3 years. This must include information on the customer's name, a short description of the delivery, its scope and duration.
Vis mer

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 12:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: norsk 🗣️
Tilbudets gyldighetsperiode: 2020-12-01 📅
Dato for åpning av tilbud: 2020-09-01 📅
Tidspunkt for åpning av tilbud: 12:00

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 994598759
Kontakt
Kontaktpunkt: Brian Mariampillai
Adresse til kjøperprofilen: http://www.nhn.no/ 🌏
URL for dokumenter: https://permalink.mercell.com/131596685.aspx 🌏

Utfyllende informasjon
Klageinstans
Navn: Oslo Tingrett
Poststed: C.J. Hambros plass 4
Postnummer: 0164
Land: Norge 🇳🇴
Organ ansvarlig for meklingsprosedyrer
Navn: Norsk helsenett
Postadresse: Verkstedveien 1
Poststed: 0277 Oslo
E-post: brian.mariampillai@nhn.no 📧
Kilde: OJS 2020/S 126-309217 (2020-06-30)